Northern Trust Corp Cin Cor Pharma, Inc. Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$10.75 - $29.84 $384,989 - $1.07 Million	35,813 Added 21.5%	202,372 $2.49 Million
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $1.05 Million - $2.05 Million	52,617 Added 46.18%	166,559 $5.47 Million
Q2 2022 Aug 12, 2022	BUY	$13.67 - $25.74 $196,096 - $369,240	14,345 Added 14.4%	113,942 $2.15 Million
Q1 2022 May 13, 2022	BUY	$14.13 - $28.49 $1.41 Million - $2.84 Million	99,597 New	99,597 $1.75 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.